Anthem (NASDAQ:ANTX) Director Robin Shane Readnour Sells 6,100 Shares of Stock

Key Points

• Director Robin Shane Readnour sold 6,100 shares of Anthem at an average price of $6.07, totaling $37,027 and reducing the position by 1.07% to 562,715 shares. The director also sold 10,019 shares on September 8 and 35,402 shares on August 17.
• Anthem shares recently traded at $5.98, with a 52-week range of $1.00 to $7.19 and a market capitalization of approximately $225.7 million. The company reported a quarterly loss of $0.18 per share.
• Institutional investors own approximately 90.47% of the stock, while analyst sentiment is mixed: two analysts rate it Buy and one rates it Sell, producing a consensus Hold rating and a $9.00 price target.

Anthem, Inc. (NASDAQ:ANTX - Get Free Report) Director Robin Shane Readnour sold 6,100 shares of the company's stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $6.07, for a total value of $37,027.00. Following the completion of the sale, the director owned 562,715 shares in the company, valued at $3,415,680.05. The trade was a 1.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Robin Shane Readnour also recently made the following trade(s):

• On Tuesday, September 8th, Robin Shane Readnour sold 10,019 shares of Anthem stock. The stock was sold at an average price of $6.02, for a total value of $60,314.38.
• On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The shares were sold at an average price of $6.01, for a total value of $212,766.02.

Anthem Price Performance

NASDAQ:ANTX traded up $0.09 during trading hours on Tuesday, reaching $5.98. The company had a trading volume of 335,287 shares, compared to its average volume of 213,148. Anthem, Inc. has a 1-year low of $1.00 and a 1-year high of $7.19. The business's 50 day moving average price is $5.33 and its 200-day moving average price is $4.41. The firm has a market cap of $225.69 million, a PE ratio of -5.59 and a beta of -0.99.

Anthem (NASDAQ:ANTX - Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Institutional Investors Weigh In On Anthem

Several large investors have recently bought and sold shares of the company. Vivo Capital LLC purchased a new stake in Anthem during the 1st quarter worth approximately $10,785,000. Commodore Capital LP purchased a new position in shares of Anthem in the first quarter valued at approximately $7,981,000. Spruce Street Capital LP acquired a new stake in shares of Anthem in the first quarter worth approximately $5,576,000. Ally Bridge Group NY LLC acquired a new stake in shares of Anthem in the first quarter worth approximately $1,800,000. Finally, Bank of America Corp DE increased its position in shares of Anthem by 2.2% during the first quarter. Bank of America Corp DE now owns 393,702 shares of the company's stock worth $1,346,000 after purchasing an additional 8,390 shares in the last quarter. 90.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently commented on the stock. Weiss Ratings restated a "sell (d-)" rating on shares of Anthem in a research report on Monday, July 6th. Wall Street Zen raised shares of Anthem from a "sell" rating to a "hold" rating in a research note on Sunday, June 14th. Guggenheim began coverage on Anthem in a research report on Monday, July 20th. They set a "buy" rating and a $9.00 target price on the stock. Finally, Leerink Partners upgraded Anthem from a "market perform" rating to an "outperform" rating and set a $9.00 price target for the company in a research note on Thursday, May 14th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $9.00.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.